Abstract: Globally, cancer affecting the breast is the most occurring cancer among women. The impact of the disease is much greater because most women delay presentation and are diagnosed with advanced stage disease, which is known to be associated with poor quality of life, reduced chance of survival and poor prognostic outcomes. Breast cancer detection and prevention are significant issues in public health and clinical practice. To achieve early detection of the disease in resource-challenged settings, integration of prevention interventions in standard medical care across all levels of cancer prevention including palliative context is paramount. A narrative review on the background information on these subjects is provided to inform future research on the phenomenon. This review was conducted as part of a study seeking to integrate breast cancer prevention into cancer palliative care in a tertiary hospital in Ghana.
Keywords: Breast cancer, delay presentation, symptom appraisal and recognition, perception, attitude and belief, breast cancer prevention and control, breast screening practices, early detection practices, palliative care, women.
[1]. Feng Y, Spezia M, Huang S, Yuan C, Zeng Z, Zhang L, Ji X, Liu W, Huang B, Luo W: Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes & Diseases 2018.
[2]. Fernandes GC, Michelli RA, Galvão HC, Paula AE, Pereira R, Andrade CE, Felicio PS, Souza CP, Mendes DR, Volc S: Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry. Oncotarget 2016, 7(49):80465
[3]. Biong M, Suderman M, Haakensen VD, Kulle B, Berg P, Gram I-T, Dumeaux V, Ursin G, Helland A, Hallet M: Candidate SNP analyses integrated with mRNA expression and hormone levels reveal influence on mammographic density and breast cancer risk. bioRxiv 2018:259002.
[4]. Zhang X, Rice M, Tworoger SS, Rosner BA, Eliassen AH, Tamimi RM, Joshi AD, Lindstrom S, Qian J, Colditz GA: Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case–control study. PLoS medicine 2018, 15(9):e1002644.
[5]. Baglia ML, Cook LS, Tang MT, Wiggins C, Hill D, Porter P, Li CI: Alcohol, Smoking, and Risk of Her2‐Overexpressing and Triple‐Negative Breast Cancer Relative to Estrogen Receptor‐Positive Breast Cancer. International journal of cancer 2018.